Evolving paradigms in the pathogenesis of IBD

Journal of Gastroenterology

Volumn 45, Issue 1, 2010, Pages 9-16

  Mayer, Lloyd ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Crohn's disease; Inflammatory bowel diseases; Pathogenesis; Ulcerative colitis

Indexed keywords

ADAPTIVE IMMUNITY; CROHN DISEASE; DISEASE COURSE; DISEASE MODEL; ENTERITIS; ENVIRONMENTAL FACTOR; GENE AMPLIFICATION; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH17 CELL; TH2 CELL; ULCERATIVE COLITIS;

ADAPTIVE IMMUNITY; ANIMALS; COLITIS, ULCERATIVE; CROHN DISEASE; DRUG DELIVERY SYSTEMS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE;

EID: 77949267597     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-009-0138-3     Document Type: Review

References (73)

1. Y Ogura DK Bonen N Inohara DL Nicolae FF Chen R Ramos H Britton T Moran R Karaliuskas RH Duerr JP Achkar SR Brant TM Bayless BS Kirschner SB Hanauer G Nunez JH Cho 2001 A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 411 603 606 10.1038/35079114 1:CAS:528: DC%2BD3MXksVShur8%3D 11385577 (Pubitemid 32531409)
2. JP Hugot M Chamaillard H Zouali S Lesage JP Cezard J Belaiche S Almer C Tysk CA O'Morain M Gassull V Binder Y Finkel A Cortot R Modigliani P Laurent-Puig C Gower-Rousseau J Macry JF Colombel M Sahbatou G Thomas 2001 Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411 599 603 10.1038/35079107 1:CAS:528:DC%2BD3MXksVShtLY%3D 11385576 (Pubitemid 32531408)
3. VD Peltekova RF Wintle LA Rubin CI Amos Q Huang X Gu B Newman M Van Oene D Cescon G Greenberg AM Griffiths PH St George-Hyslop KA Siminovitch 2004 Functional variants of OCTN cation transporter genes are associated with Crohn disease Nat Genet 36 471 475 10.1038/ng1339 1:CAS:528:DC%2BD2cXjsFSntrg%3D 15107849 (Pubitemid 38620030)
4. SR Brant CI Panhuysen D Nicolae DM Reddy DK Bonen R Karaliukas L Zhang E Swanson LW Datta T Moran G Ravenhill RH Duerr JP Achkar AS Karban JH Cho 2003 MDR1 Ala893 polymorphism is associated with inflammatory bowel disease Am J Hum Genet 73 1282 1292 10.1086/379927 1:CAS:528:DC%2BD2cXitlSh 14610718 (Pubitemid 38037422)
5. J Hampe A Franke P Rosenstiel A Till M Teuber K Huse M Albrecht G Mayr FM De La Vega J Briggs S Gunther NJ Prescott CM Onnie R Hasler B Sipos UR Folsch T Lengauer M Platzer CG Mathew M Krawczak S Schreiber 2007 A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 Nat Genet 39 207 211 10.1038/ng1954 1:CAS:528:DC%2BD2sXpvFerug%3D%3D 17200669 (Pubitemid 46184351)
6. JD Rioux RJ Xavier KD Taylor MS Silverberg P Goyette A Huett T Green P Kuballa MM Barmada LW Datta YY Shugart AM Griffiths SR Targan AF Ippoliti EJ Bernard L Mei DL Nicolae M Regueiro LP Schumm AH Steinhart JI Rotter RH Duerr JH Cho MJ Daly SR Brant 2007 Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis Nat Genet 39 596 604 10.1038/ng2032 1:CAS:528:DC%2BD2sXksFersbk%3D 17435756 (Pubitemid 46676115)
7. RH Duerr KD Taylor SR Brant JD Rioux MS Silverberg MJ Daly AH Steinhart C Abraham M Regueiro A Griffiths T Dassopoulos A Bitton H Yang S Targan LW Datta EO Kistner LP Schumm AT Lee PK Gregersen MM Barmada JI Rotter DL Nicolae JH Cho 2006 A genome-wide association study identifies IL23R as an inflammatory bowel disease gene Science 314 1461 1463 10.1126/science.1135245 1:CAS:528: DC%2BD28Xht1CntrjF 17068223 (Pubitemid 44871953)
8. DK Podolsky 1997 Lessons from genetic models of inflammatory bowel disease Acta Gastroenterol Belg 60 163 165 1:STN:280:DyaK2svgs12rsA%3D%3D 9260328
9. W Strober I Fuss P Mannon 2007 The fundamental basis of inflammatory bowel disease J Clin Invest 117 514 521 10.1172/JCI30587 1:CAS:528: DC%2BD2sXis12hsbk%3D 17332878 (Pubitemid 46348505)
10. J Braun SR Targan 2006 Multiparameter analysis of immunogenetic mechanisms in clinical diagnosis and management of inflammatory bowel disease Adv Exp Med Biol 579 209 218 10.1007/0-387-33778-4-13 1:CAS:528: DC%2BD1MXhtFWjtLk%3D 16620020
11. R Duchmann I Kaiser E Hermann W Mayet K Ewe KH Meyer zum Buschenfelde 1995 Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) Clin Exp Immunol 102 448 455 1:STN:280:DyaK287ivVWgsw%3D%3D 8536356
12. AM Mowat JL Viney 1997 The anatomical basis of intestinal immunity Immunol Rev 156 145 166 10.1111/j.1600-065X.1997.tb00966.x 1:STN:280: DyaK2szhvFyiug%3D%3D 9176706
13. J Maul C Loddenkemper P Mundt E Berg T Giese A Stallmach M Zeitz R Duchmann 2005 Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease Gastroenterology 128 1868 1878 10.1053/j.gastro.2005. 03.043 1:CAS:528:DC%2BD2MXlvFKlsLo%3D 15940622 (Pubitemid 40824698)
14. C Mottet HH Uhlig F Powrie 2003 Cutting edge: cure of colitis by CD4+ CD25+ regulatory T cells J Immunol 170 3939 3943 1:CAS:528:DC%2BD3sXislektbk%3D 12682220
15. J Brimnes M Allez I Dotan L Shao A Nakazawa L Mayer 2005 Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease J Immunol 174 5814 5822 1:CAS:528:DC%2BD2MXjsVeqs7o%3D 15843585
16. DB Sachar 2002 Genomics and phenomics in Crohn's disease Gastroenterology 122 1161 1162 10.1053/gast.2002.32754 11910366
17. DM Spencer GM Veldman S Banerjee J Willis AD Levine 2002 Distinct inflammatory mechanisms mediate early versus late colitis in mice Gastroenterology 122 94 105 10.1053/gast.2002.30308 11781285
18. P Rutgeerts G Van Assche S Vermeire 2004 Optimizing anti-TNF treatment in inflammatory bowel disease Gastroenterology 126 1593 1610 10.1053/j.gastro. 2004.02.070 1:CAS:528:DC%2BD2cXltFyjtL4%3D 15168370 (Pubitemid 38649876)
19. L Halme P Paavola-Sakki U Turunen M Lappalainen M Farkkila K Kontula 2006 Family and twin studies in inflammatory bowel disease World J Gastroenterol 12 3668 3672 16773682
20. M Orholm V Binder TI Sorensen LP Rasmussen KO Kyvik 2000 Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study Scand J Gastroenterol 35 1075 1081 10.1080/003655200451207 1:STN:280: DC%2BD3MzgsFyjtQ%3D%3D 11099061
21. J Satsangi M Parkes DP Jewell JI Bell 1998 Genetics of inflammatory bowel disease Clin Sci (Lond) 94 473 478 1:STN:280:DyaK1czkslGqsg%3D%3D
22. CN Bernstein P Rawsthorne M Cheang JF Blanchard 2006 A population-based case control study of potential risk factors for IBD Am J Gastroenterol 101 993 1002 10.1111/j.1572-0241.2006.00381.x 16696783 (Pubitemid 43725312)
23. SR Brant YY Shugart 2004 Inflammatory bowel disease gene hunting by linkage analysis: rationale, methodology, and present status of the field Inflamm Bowel Dis 10 300 311 10.1097/00054725-200405000-00019 15290927 (Pubitemid 38618262)
24. N Esters M Pierik K van Steen S Vermeire G Claessens S Joossens R Vlietinck P Rutgeerts 2004 Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease Am J Gastroenterol 99 299 305 10.1111/j.1572-0241.2004.04040.x 1:CAS:528:DC%2BD2cXitleisLc%3D 15046221 (Pubitemid 38279873)
25. B Weiss R Shamir Y Bujanover M Waterman C Hartman A Fradkin D Berkowitz I Weintraub R Eliakim A Karban 2004 NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohn's disease J Pediatr 145 208 212 10.1016/j.jpeds.2004.05.024 1:CAS:528:DC%2BD2cXmt1Chsb0%3D 15289769 (Pubitemid 38993393)
26. MT Abreu KD Taylor YC Lin T Hang J Gaiennie CJ Landers EA Vasiliauskas LY Kam M Rojany KA Papadakis JI Rotter SR Targan H Yang 2002 Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease Gastroenterology 123 679 688 10.1053/gast.2002.35393 1:CAS:528: DC%2BD38Xntl2mtbo%3D 12198692 (Pubitemid 34977073)
27. J Halfvarson L Bodin C Tysk E Lindberg G Jarnerot 2003 Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics Gastroenterology 124 1767 1773 10.1016/S0016-5085(03) 00385-8 12806610 (Pubitemid 36666773)
28. J Halfvarson T Jess L Bodin G Jarnerot P Munkholm V Binder C Tysk 2007 Longitudinal concordance for clinical characteristics in a Swedish-Danish twin population with inflammatory bowel disease Inflamm Bowel Dis 13 1536 1544 10.1002/ibd.20242 17828780
29. M Chiba T Fukushima Y Horie M Iizuka O Masamune 1998 No Mycobacterium paratuberculosis detected in intestinal tissue, including Peyer's patches and lymph follicles, of Crohn's disease J Gastroenterol 33 482 487 10.1007/s005350050119 1:CAS:528:DyaK1cXkvVahtr8%3D 9719229 (Pubitemid 28376976)
30. DA Drossman 1998 Presidential address: gastrointestinal illness and the biopsychosocial model Psychosom Med 60 258 267 1:STN:280:DyaK1c3os1yktA%3D%3D 9625212
31. R Medzhitov C Janeway Jr 2000 Innate immune recognition: mechanisms and pathways Immunol Rev 173 89 97 10.1034/j.1600-065X.2000.917309.x 1:CAS:528:DC%2BD3cXhs1Gqsr4%3D 10719670 (Pubitemid 30095213)
32. CA Janeway Jr K Bottomly 1994 Signals and signs for lymphocyte responses Cell 76 275 285 10.1016/0092-8674(94)90335-2 1:CAS:528:DyaK2cXhs1Srtro%3D 7904901
33. R Medzhitov CA Janeway Jr 1998 Innate immune recognition and control of adaptive immune responses Semin Immunol 10 351 353 10.1006/smim.1998.0136 1:CAS:528:DyaK1cXnsVekt70%3D 9799709 (Pubitemid 28499548)
34. JS Huang D Noack J Rae BA Ellis R Newbury AL Pong JE Lavine JT Curnutte J Bastian 2004 Chronic granulomatous disease caused by a deficiency in p47(phox) mimicking Crohn's disease Clin Gastroenterol Hepatol 2 690 695 10.1016/S1542-3565(04)00292-7 1:CAS:528:DC%2BD2cXnt1OisL0%3D 15290662 (Pubitemid 39013429)
35. RA Schinella MA Greco BL Cobert LW Denmark RP Cox 1980 Hermansky-Pudlak syndrome with granulomatous colitis Ann Int Med 92 20 23 1:STN:280: DyaL3c%2Fos1Wqsw%3D%3D 7350869
36. BK Dieckgraefe JR Korzenik 2002 Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor Lancet 360 1478 1480 10.1016/S0140-6736(02)11437-1 12433518 (Pubitemid 35356328)
37. S Kugathasan LJ Saubermann L Smith D Kou J Itoh DG Binion AD Levine RS Blumberg C Fiocchi 2007 Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease Gut 56 1696 1705 10.1136/gut.2006.116467 1:CAS:528:DC%2BD1cXmsFKmuw%3D%3D 17682002 (Pubitemid 350206296)
38. SJ Brown L Mayer 2007 The immune response in inflammatory bowel disease Am J Gastroenterol 102 2058 2069 10.1111/j.1572-0241.2007.01343.x 1:CAS:528:DC%2BD2sXhtFGgtb3P 17561966 (Pubitemid 47301524)
39. IJ Fuss F Heller M Boirivant F Leon M Yoshida S Fichtner-Feigl Z Yang M Exley A Kitani RS Blumberg P Mannon W Strober 2004 Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis J Clin Invest 113 1490 1497 1:CAS:528:DC%2BD2cXktlClt70%3D 15146247
40. IJ Fuss M Neurath M Boirivant JS Klein C de la Motte SA Strong C Fiocchi W Strober 1996 Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5 J Immunol 157 1261 1270 1:CAS:528:DyaK28XksFKhtLY%3D 8757634
41. G van Assche 2007 Emerging drugs to treat Crohn's disease Expert Opin Emerg Drugs 12 49 59 10.1517/14728214.12.1.49 17355213 (Pubitemid 46490732)
42. K Kobayashi K Kaneda T Kasama 2001 Immunopathogenesis of delayed-type hypersensitivity Microsc Res Tech 53 241 245 10.1002/jemt.1090 1:CAS:528:DC%2BD3MXksVyhs7o%3D 11340669 (Pubitemid 32467161)
43. LH Glimcher 2007 Trawling for treasure: tales of T-bet Nat Immunol 8 448 450 10.1038/ni0507-448 1:CAS:528:DC%2BD2sXkt1Khs7k%3D 17440449 (Pubitemid 46605908)
44. C Berlin EL Berg MJ Briskin DP Andrew PJ Kilshaw B Holzmann IL Weissman A Hamann EC Butcher 1993 Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1 Cell 74 185 195 10.1016/0092-8674(93) 90305-A 1:CAS:528:DyaK3sXltlOhtb0%3D 7687523 (Pubitemid 23219889)
45. TT MacDonald M Bajaj-Elliott SL Pender 1999 T cells orchestrate intestinal mucosal shape and integrity Immunol Today 20 505 510 10.1016/S0167-5699(99)01536-4 1:CAS:528:DyaK1MXmvVKhsLw%3D 10529778 (Pubitemid 29507094)
46. Alber G, Al-Robaiy S, Kleinschek M, Knauer J, Krumbholz P, Richter J, Schoeneberger S, Schuetze N, Schulz S, Toepfer K, Voigtlaender R, Lehmann J, Mueller U. Induction of immunity and inflammation by interleukin-12 family members. Ernst Schering Res Found Workshop 2006:107-27.
47. CA Hunter 2005 New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions Nat Rev Immunol 5 521 531 10.1038/nri1648 1:CAS:528:DC%2BD2MXlsl2isbY%3D 15999093 (Pubitemid 40961330)
48. H Elloumi-Zghal MR Barbouche J Chemli M Bejaoui A Harbi N Snoussi S Abdelhak K Dellagi 2002 Clinical and genetic heterogeneity of inherited autosomal recessive susceptibility to disseminated Mycobacterium bovis bacille calmette-guerin infection J Infect Dis 185 1468 1475 10.1086/340510 1:CAS:528:DC%2BD38XksVCjtbg%3D 11992283 (Pubitemid 34507970)
49. T Sakai M Matsuoka M Aoki K Nosaka H Mitsuya 2001 Missense mutation of the interleukin-12 receptor beta1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection Blood 97 2688 2694 10.1182/blood.V97.9.2688 1:CAS:528:DC%2BD3MXjtlSiurg%3D 11313259
50. CT Weaver RD Hatton PR Mangan LE Harrington 2007 IL-17 family cytokines and the expanding diversity of effector T cell lineages Annu Rev Immunol 25 821 852 10.1146/annurev.immunol.25.022106.141557 1:CAS:528:DC%2BD2sXltlans7s%3D 17201677 (Pubitemid 46697925)
51. L Zhou II Ivanov R Spolski R Min K Shenderov T Egawa DE Levy WJ Leonard DR Littman 2007 IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways Nat Immunol 8 967 974 10.1038/ni1488 1:CAS:528:DC%2BD2sXptlSkurw%3D 17581537 (Pubitemid 47300011)
52. S Fujino A Andoh S Bamba A Ogawa K Hata Y Araki T Bamba Y Fujiyama 2003 Increased expression of interleukin 17 in inflammatory bowel disease Gut 52 65 70 10.1136/gut.52.1.65 1:CAS:528:DC%2BD3sXmtVyqsw%3D%3D 12477762 (Pubitemid 36020767)
53. IJ Fuss C Becker Z Yang C Groden RL Hornung F Heller MF Neurath W Strober PJ Mannon 2006 Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody Inflamm Bowel Dis 12 9 15 10.1097/01.MIB.0000194183.92671.b6 16374252 (Pubitemid 43032445)
54. DT Umetsu RH DeKruyff 1997 Th1 and Th2 CD4+ cells in the pathogenesis of allergic diseases Proc Soc Exp Biol Med 215 11 20 1:CAS:528:DyaK2sXjtFKrsrc%3D 9142134
55. G Bouma W Strober 2003 The immunological and genetic basis of inflammatory bowel disease Nat Rev Immunol 3 521 533 10.1038/nri1132 1:CAS:528:DC%2BD3sXls1Smtr4%3D 12876555 (Pubitemid 37328672)
56. F Heller P Florian C Bojarski J Richter M Christ B Hillenbrand J Mankertz AH Gitter N Burgel M Fromm M Zeitz I Fuss W Strober JD Schulzke 2005 Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution Gastroenterology 129 550 564 1:CAS:528:DC%2BD2MXpvVWmsLc%3D 16083712
57. P Rutgeerts WJ Sandborn BG Feagan W Reinisch A Olson J Johanns S Travers D Rachmilewitz SB Hanauer GR Lichtenstein WJ de Villiers D Present BE Sands JF Colombel 2005 Infliximab for induction and maintenance therapy for ulcerative colitis N Engl J Med 353 2462 2476 10.1056/NEJMoa050516 1:CAS:528: DC%2BD2MXhtlShurjE 16339095 (Pubitemid 41770166)
58. F Annunziato L Cosmi V Santarlasci L Maggi F Liotta B Mazzinghi E Parente L Fili S Ferri F Frosali F Giudici P Romagnani P Parronchi F Tonelli E Maggi S Romagnani 2007 Phenotypic and functional features of human Th17 cells J Exp Med 204 1849 1861 10.1084/jem.20070663 1:CAS:528:DC%2BD2sXptVyjsLs%3D 17635957 (Pubitemid 47240944)
59. TL Denning H Qi R Konig KG Scott M Naganuma PB Ernst 2003 CD4+ Th cells resembling regulatory T cells that inhibit chronic colitis differentiate in the absence of interactions between CD4 and class II MHC J Immunol 171 2279 2286 1:CAS:528:DC%2BD3sXmsVOrtr8%3D 12928372
60. N Hosoe S Miura C Watanabe Y Tsuzuki R Hokari T Oyama Y Fujiyama H Nagata H Ishii 2004 Demonstration of functional role of TECK/CCL25 in T lymphocyte-endothelium interaction in inflamed and uninflamed intestinal mucosa Am J Physiol Gastrointest Liver Physiol 286 G458 G466 10.1152/ajpgi.00167.2003 1:CAS:528:DC%2BD2cXitlSgtL0%3D 14592943
61. B Lu A Humbles D Bota C Gerard B Moser D Soler AD Luster NP Gerard 1999 Structure and function of the murine chemokine receptor CXCR3 Eur J Immunol 29 3804 3812 10.1002/(SICI)1521-4141(199911)29:11<3804::AID-IMMU3804>3.0. CO;2-9 1:CAS:528:DyaK1MXnt1Ogu78%3D 10556837 (Pubitemid 29527830)
62. MF Neurath S Finotto I Fuss M Boirivant PR Galle W Strober 2001 Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question Trends Immunol 22 21 26 10.1016/S1471-4906(00) 01798-1 1:CAS:528:DC%2BD3MXhslantrY%3D 11286687 (Pubitemid 32675276)
63. S Ghosh E Goldin FH Gordon HA Malchow J Rask-Madsen P Rutgeerts P Vyhnalek Z Zadorova T Palmer S Donoghue 2003 Natalizumab for active Crohn's disease N Engl J Med 348 24 32 10.1056/NEJMoa020732 1:CAS:528: DC%2BD3sXhsVSltg%3D%3D 12510039 (Pubitemid 36026343)
64. GL Stephens EM Shevach 2007 Foxp3+ regulatory T cells: Selfishness under scrutiny Immunity 27 417 419 10.1016/j.immuni.2007.08.008 1:CAS:528: DC%2BD2sXhtFWmu7bE 17892850 (Pubitemid 47418676)
65. Y Zheng AY Rudensky 2007 Foxp3 in control of the regulatory T cell lineage Nat Immunol 8 457 462 10.1038/ni1455 1:CAS:528:DC%2BD2sXkt1Khtr8%3D 17440451 (Pubitemid 46605910)
66. Y Cong CT Weaver A Lazenby CO Elson 2002 Bacterial-reactive T regulatory cells inhibit pathogenic immune responses to the enteric flora J Immunol 169 6112 6119 1:CAS:528:DC%2BD38Xpt1Kmtbg%3D 12444113
67. DM Rennick MM Fort NJ Davidson 1997 Studies with IL-10-/- mice: an overview J Leukoc Biol 61 389 396 1:CAS:528:DyaK2sXisFOrsrY%3D 9103224
68. RL Coffman DA Lebman B Shrader 1989 Transforming growth factor beta specifically enhances IgA production by lipopolysaccharide-stimulated murine B lymphocytes J Exp Med 170 1039 1044 10.1084/jem.170.3.1039 1:CAS:528: DyaL1MXls1yju7s%3D 2788703
69. FM Ruemmele N Brousse O Goulet 2004 Autoimmune enteropathy: molecular concepts Curr Opin Gastroenterol 20 587 591 10.1097/00001574-200411000-00014 15703687 (Pubitemid 39447169)
70. HD Ochs E Gambineri TR Torgerson 2007 IPEX, FOXP3 and regulatory T-cells: a model for autoimmunity Immunol Res 38 112 121 10.1007/s12026-007-0022-2 1:CAS:528:DC%2BD2sXhtlWjsrjM 17917016 (Pubitemid 47574902)
71. M Allez J Brimnes I Dotan L Mayer 2002 Expansion of CD8+ T cells with regulatory function after interaction with intestinal epithelial cells Gastroenterology 123 1516 1526 10.1053/gast.2002.36588 12404227
72. TA Kraus L Toy L Chan J Childs A Cheifetz L Mayer 2004 Failure to induce oral tolerance in Crohn's and ulcerative colitis patients: possible genetic risk Ann N Y Acad Sci 1029 225 238 10.1196/annals.1309.054 1:CAS:528: DC%2BD2MXislWisbs%3D 15681761 (Pubitemid 40298533)
73. TA Kraus L Toy L Chan J Childs L Mayer 2004 Failure to induce oral tolerance to a soluble protein in patients with inflammatory bowel disease Gastroenterology 126 1771 1778 10.1053/j.gastro.2004.03.076 1:CAS:528: DC%2BD2cXlsFaqs7w%3D 15188172 (Pubitemid 38736342)